NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease

International Journal of Cardiology

Volumn 165, Issue 1, 2013, Pages 184-192

  Loffredo, Lorenzo ^a   Carnevale, Roberto ^a   Cangemi, Roberto ^a   Angelico, Francesco ^a   Augelletti, Teresa ^a   Di Santo, Serena ^a   Calabrese, Cinzia M ^a   Della Volpe, Luigi ^a   Pignatelli, Pasquale ^a   Perri, Ludovica ^a   Basili, Stefania ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Flow mediated dilation; Nitric oxide; Oxidative stress; Peripheral artery disease; Propionylcarnitine

Indexed keywords

ISOPROSTANE DERIVATIVE; NITRATE; NITRITE; PLACEBO; PROPIONYLCARNITINE; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC OXIDE; ORAL ANTIDIABETIC AGENT; PEPTIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AGED; ARTERIAL INSUFFICIENCY; ARTERY DILATATION; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE CULTURE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; TREATMENT DURATION; UPREGULATION; ARTERY DISEASE; BLOOD LEVEL; CATALYSIS; DIABETES MELLITUS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DYSLIPIDEMIA; ENZYME INDUCTION; FLOW MEDIATED DILATION IMPAIRMENT; INTERVENTION STUDY; LEUKOCYTE; NITRATE BLOOD LEVEL; NITRITE BLOOD LEVEL; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2 BLOOD LEVEL; URINE LEVEL; VASODILATATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NADPH OXIDASE; PERIPHERAL ARTERIAL DISEASE; REACTIVE OXYGEN SPECIES; UP-REGULATION; VASODILATION;

EID: 84876132783     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.069     Document Type: Article

References (34)

1. J. Dormandy, M. Mahir, and G. Ascady Fate of the patient with chronic leg ischaemia. A review article J Cardiovasc Surg (Torino) 30 1989 50 57
2. A.T. Hirsch, Z.J. Haskal, and N.R. Hertzer ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
3. M.C. Corretti, T.J. Anderson, and E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
4. A. Silvestro, F. Scopacasa, and A. Ruocco Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease Vasc Med 8 2003 225 232
5. G. Brevetti, A. Silvestro, V. Schiano, and M. Chiariello Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index Circulation 108 2003 2093 2098
6. R. Joannides, W.E. Haefeli, and L. Linder Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo Circulation 91 1995 1314 1319
7. J.P. Cooke Flow, NO, and atherogenesis Proc Natl Acad Sci U S A 100 2003 768 770
8. C. Heiss, T. Lauer, and A. Dejam Plasma nitroso compounds are decreased in patients with endothelial dysfunction J Am Coll Cardiol 47 2006 573 579
9. L. Loffredo, A. Marcoccia, and P. Pignatelli Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease Eur Heart J 28 2007 608 612
10. H. Cai, and D.G. Harrison Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress Circ Res 87 2000 840 844
11. U. Forstermann Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies Nat Clin Pract Cardiovasc Med 5 2008 338 349
12. J.K. Bendall, R. Rinze, and D. Adlam Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice Circ Res 100 2007 1016 1025
13. -/- mice Arterioscler Thromb Vasc Biol 26 2006 1753 1759
14. O. Jung, J.G. Schreiber, H. Geiger, T. Pedrazzini, R. Busse, and R.P. Brandes gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension Circulation 109 2004 1795 1801
15. F. Violi, V. Sanguigni, and R. Carnevale Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study Circulation 120 2009 1616 1622
16. P. Pignatelli, R. Carnevale, and R. Cangemi Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia Arterioscler Thromb Vasc Biol 30 2010 360 367
17. M.A. Martínez-González, E. Fernández-Jarne, M. Serrano-Martínez, M. Wright, and E. Gomez-Gracia Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet Eur J Clin Nutr 58 2004 1550 1552
18. S.W. Hoffman, R.L. Roof, and D.G. Stein A reliable and sensitive enzyme immunoassay method for measuring 8-isoprostaglandin F2 alpha: a marker for lipid peroxidation after experimental brain injury J Neurosci Methods 68 1996 133 136
19. A.S. Lawrie, A. Albanyan, R.A. Cardigan, I.J. Mackie, and P. Harrison Microparticle sizing by dynamic light scattering in fresh-frozen plasma Vox Sang 96 2009 206 212
20. P. Pignatelli, R. Carnevale, and S. Di Santo Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction Arterioscler Thromb Vasc Biol 31 2011 423 434
21. A. Fortuno, J. Bidegain, and P.A. Robador Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension Hypertension 54 2009 744 750
22. P. Poredos, M. Golob, and M. Jensterle Interrelationship between peripheral arterial occlusive disease, carotid atherosclerosis and flow mediated dilation of the brachial artery Int Angiol 22 2003 83 87
23. L.E. Chambless, A.R. Folsom, and L.X. Clegg Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study Am J Epidemiol 151 2000 478 487
24. M. Rosvall, L. Janzon, G. Berglund, G. Engstrom, and B. Hedblad Incidence of stroke is related to carotid IMT even in the absence of plaque Atherosclerosis 179 2005 325 331
25. M.W. Lorenz, S. von Kegler, H. Steinmetz, H.S. Markus, and M. Sitzer Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis ProgressionStudy (CAPS) Stroke 37 2006 87 92
26. A.C. Cave, A.C. Brewer, and A. Narayanapanicker NADPH oxidases in cardiovascular health and disease Antioxid Redox Signal 8 2006 691 728
27. C. Dewas, P.M. Dang, M.A. Gougerot-Pocidalo, and J. El-Benna TNF-alpha induces phosphorylation of p47(phox) in human neutrophils: partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-alpha and granulocyte-macrophage colony-stimulating factor J Immunol 171 2003 4392 4398
28. S.S. Signorelli, M.C. Mazzarino, and L. Di Pino High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test Vasc Med 8 2003 15 19
29. J.O. Lundberg, and E. Weitzberg NO generation from nitrite and its role in vascular control Arterioscler Thromb Vasc Biol 25 2005 915 922
30. P. Pignatelli, L. Lenti, and V. Sanguigni Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress Am J Physiol Heart Circ Physiol 284 2003 H41 H48
31. M.A. Stasi, M.G. Scioli, and G. Arcuri Propionyl-l-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production Arterioscler Thromb Vasc Biol 30 2010 426 435
32. A.E. Dikalova, M.C. Góngora, D.G. Harrison, J.D. Lambeth, S. Dikalov, and K.K. Griendling Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling Am J Physiol Heart Circ Physiol 299 2010 H673 H679
33. R. Stroh, T.A. Christopher, B.L. Lopez, Y.P. Guo, M. Amico-Roxas, and X.L. Ma l-propionyl carnitine, an endogenous ester in fatty acid metabolism, exerts anti-shock and endothelial protective effects in rat splanchnic ischemia-reperfusion injury Shock 9 1998 216 222
34. A. Bertelli, A. Conte, G. Ronca, D. Segnini, and G. Yu Protective effect of propionyl carnitine against peroxidative damage to arterial endothelium membranes Int J Tissue React 13 1991 41 43